Overview

Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent DepressionSMART-I)

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
This project aims to investigate the effectiveness of existing common antidepressants in adolescents with MDD who did not respond to their first treatment.
Phase:
PHASE4
Details
Lead Sponsor:
Xinyu Zhou
Treatments:
agomelatine
Aripiprazole
Sertraline